Novonesis (NVZMY)
OTHER OTC:NVZMY
Holding NVZMY?
Track your performance easily

Novonesis (NVZMY) Income Statement

67 Followers

Novonesis Income Statement

Last quarter (Q4 2022), Novonesis's total revenue was kr4.53B, an increase of 18.13% from the same quarter last year. In Q4, Novonesis's net income was kr883.00M. See Novonesis’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
kr 17.55B-kr 17.55Bkr 14.95Bkr 14.01Bkr 14.37B
Cost of Revenue
kr 7.98B-kr 7.98Bkr 6.33Bkr 6.16Bkr 6.42B
Gross Profit
kr 9.58B-kr 9.58Bkr 8.62Bkr 7.85Bkr 7.95B
Operating Expense
kr 5.15B-kr 5.15Bkr 4.74Bkr 4.24Bkr 4.41B
Operating Income
kr 4.43B-kr 4.43Bkr 3.88Bkr 3.61Bkr 3.54B
Net Non Operating Interest Income Expense
kr -183.00M-kr -183.00Mkr -104.00Mkr -84.00Mkr -25.00M
Other Income Expense
------
Pretax Income
kr 4.56B-kr 4.56Bkr 3.92Bkr 3.52Bkr 3.80B
Tax Provision
kr 870.00M-kr 870.00Mkr 779.00Mkr 695.00Mkr 644.00M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
kr 3.68B-kr 3.68Bkr 3.15Bkr 2.83Bkr 3.15B
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
kr 13.13B-kr 13.13Bkr 11.07Bkr 10.40Bkr 10.83B
Net Income From Continuing And Discontinued Operation
kr 3.68B-kr 3.68Bkr 3.15Bkr 2.83Bkr 3.15B
Normalized Income
kr 3.68B-kr 3.64Bkr 2.95Bkr 2.78Bkr 2.87B
Interest Expense
--kr 102.00Mkr 102.00Mkr 63.00Mkr 86.00M
EBIT
kr 4.66B-kr 4.66Bkr 4.03Bkr 3.58Bkr 3.88B
EBITDA
kr 4.66Bkr 5.47Bkr 6.12Bkr 5.40Bkr 4.85Bkr 5.07B
Currency in DKK

Novonesis Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis